NuSep Extends Closing Date on Share Purchase Offer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.

It added that to date, it has received about A$1.3 million ($1.4 million) of a targeted amount of A$2.1 million. The offering, which was announced in July and which had an original closing date of July 29, had been extended previously to Aug. 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.